Role of endoscopic ultrasound in pancreatic cancer

Expert Review of Gastroenterology and Hepatology

Volumn 3, Issue 3, 2009, Pages 293-303

  Chang, David K ^a,b   Nguyen, Nam Q ^a,b   Merrett, Neil D ^a,b   Dixson, Hugh ^a   Leong, Rupert W L ^a   Biankin, Andrew V ^a,b  

^a BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Endoscopic ultrasound; Fine needle aspiration biopsy; Management algorithm; Pancreatic cancer; Pancreatic surgery; Pancreatology

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; FLUORODEOXYGLUCOSE; TNFERADE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ASPIRATION BIOPSY; BLEEDING; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PAIN; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELIAC PLEXUS; CHRONIC PANCREATITIS; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEVER; HUMAN; INJECTION SITE PAIN; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEUROLYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; STENT; SURVIVAL RATE; ALGORITHM; ECHOGRAPHY; NEEDLE BIOPSY; PANCREAS TUMOR; PATHOLOGY;

ALGORITHMS; BIOPSY, FINE-NEEDLE; ENDOSONOGRAPHY; HUMANS; NEOPLASM STAGING; PANCREATIC NEOPLASMS;

EID: 68149105821     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/egh.09.18     Document Type: Review

References (86)

1. Yasuda K, Mukai H, Fujimoto S, Nakajima M, Kawai K. The diagnosis of pancreatic cancer by endoscopic ultrasonography. Gastrointest. Endosc. 34(1), 1-8 (1988).
2. Rosch T, Lorenz R, Braig C et al. Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest. Endosc. 37(3), 347-352 (1991).
3. Chaya CT, Bhutani MS. Ultrasonography of the pancreas. 6. Endoscopic imaging. Abdom. Imaging 32(2), 191-199 (2007).
4. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J. Clin. 58(2), 71-96 (2008).
5. Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann. Surg. 244(1), 10-15 (2006).
6. Yeo CJ, Cameron JL, Sohn TA et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann. Surg. 226(3), 248-257 (1997).
7. Rivadeneira DE, Pochapin M, Grobmyer SR et al. Comparison of linear array endoscopic ultrasound and helical computed tomography for the staging of periampullary malignancies. Ann. Surg. Oncol. 10(8), 890-897 (2003).
8. Raut CP, Grau AM, Staerkel GA et al. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J. Gastrointest. Surg. 7(1), 118-126; discussion 127-118 (2003).
9. DeWitt J, Devereaux B, Chriswell M et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann. Intern. Med. 141(10), 753-763 (2004).
10. Agarwal B, Abu-Hamda E, Molke KL, Correa AM, Ho L. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am. J. Gastroenterol. 99(5), 844-850 (2004).
11. Tamm EP, Loyer EM, Faria SC, Evans DB, Wolff RA, Charnsangavej C. Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. Abdom. Imaging 32(5), 660-667 (2007).
12. Rosch T, Schusdziarra V, Born P et al. Modern imaging methods versus clinical assessment in the evaluation of hospital in-patients with suspected pancreatic disease. Am. J. Gastroenterol. 95(9), 2261-2270 (2000).
13. Harewood GC, Wiersema MJ. Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses. Am. J. Gastroenterol. 97(6), 1386-1391 (2002).
14. Eloubeidi MA, Varadarajulu S, Desai S et al. A prospective evaluation of an algorithm incorporating routine preoperative endoscopic ultrasound-guided fine needle aspiration in suspected pancreatic cancer. J. Gastrointest. Surg. 11(7), 813-819 (2007).
15. Puli SR, Singh S, Hagedorn CH, Reddy J, Olyaee M. Diagnostic accuracy of EUS for vascular invasion in pancreatic and periampullary cancers: a meta-analysis and systematic review. Gastrointest. Endosc. 65(6), 788-797 (2007).
16. Ho JM, Eysselein VE, Stabile BE. The value of endoscopic ultrasonography in predicting resectability and margins of resection for periampullary tumors. Am. Surg. 74(10). 1026-1029 (2008).
17. Bao PQ, Johnson JC, Lindsey EH et al. Endoscopic ultrasound and computed tomography predictors of pancreatic cancer resectability. J. Gastrointest. Surg. 12(1), 1.0-16; discussion 16 (2008).
18. Yovino S, Darwin P, Daly B, Garofalo M, Moesinger R. Predicting unresectability in pancreatic cancer patients: the additive effects of CT and endoscopic ultrasound. J. Gastrointest. Surg. 11(1), 36-42 (2007).
19. Vilman P, Jacobsen GK, Henriksen FW, Hanke S. Endoscopic ultrasonography with guided fine needle aspiration biopsy in pancreatic disease. Gastrointest. Endosc. 38, 172-173 (1992).
20. Paquin SC, Gariepy G, Lepanto L, Bourdages R, Raymond G, Sahai AV. A first report of tumor seeding because of EUS-guided FNA of a pancreatic adenocarcinoma. Gastrointest. Endosc. 61(4), 610-611 (2005).
21. Yamao K, Sawaki A, Mizuno N, Shimizu Y, Yatabe Y, Koshikawa T. Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB): past, present, and future. J. Gastroenterol. 40(11), 1013-1023 (2005).
22. Abraham SC, Wilentz RE, Yeo CJ et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all 'chronic pancreatitis'? Am. J. Surg. Pathol. 27(1), 110-120 (2003).
23. Brand RE, Lerch MM, Rubinstein WS et al. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 56(10), 1460-1469 (2007).
24. Larghi A, Verna EC, Lecca PG, Costamagna G. Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound. Clin. Cancer Res. 15(6), 1907-1914 (2009).
25. Canto MI. Screening and surveillance approaches in familial pancreatic cancer. Gastrointest. Endosc. Clip. N. Am. 18(3), 535-553 (2008).
26. Canto MI, Goggins M, Hruban RH et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin. Gastroenterol. Hepatol. 4(6), 766-781 (2006).
27. Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey MB. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann. Intern. Med. 131(4), 247-255 (1999).
28. Kimmey MB, Bronner MP, Byrd DR, Brentnall TA. Screening and surveillance for hereditary pancreatic cancer. Gastrointest. Endosc. 56(4 Suppl.), S82-S86 (2002).
29. Canto MI, Goggins M, Yeo CJ et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin. Gastroenterol. Hepatol. 2(7), 606-621 (2004).
30. Yan BM, Myers RP. Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer. Am. J. Gastroenterol. 102(2), 430-438 (2007).
31. Lillemoe KD, Cameron JL, Kaufman HS, Yeo CJ, Pitt HA, Sauter PK. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann. Surg. 217(5), 447-455; discussion 456-447 (1993).
32. Michaels AJ, Draganov PV. Endoscopic ultrasonography guided celiac plexus neurolysis and celiac plexus block in the management of pain due to pancreatic cancer and chronic pancreatitis. World J. Gastroenterol. 13(26), 3575-3580 (2007).
33. Levy MJ, Topazian MD, Wiersema MJ et al. Initial evaluation of the efficacy and safety of endoscopic ultrasound-guided direct ganglia neurolysis and block. Am. J. Gastroenterol. 103(1), 98-103 (2008).
34. Chang KJ, Senzer N, Chung T. A novel gene transfer therapy against pancreatic cancer (TNFerade) delivered by endoscopic ultrasound (EUS) and percutaneous guided fine needle injection (FNI). Gastrointest. Endosc. 59 (2004).
35. Senzer N, Mani S, Rosemurgy A et al. TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor α gene: a Phase I study in patients with solid tumors. J. Clin. Oncol. 22(4), 592-601 (2004).
36. Farrell JJ, Senzer N, Hecht JR et al. Long-term data for endoscopic ultrasound (EUS) and percutanous (PTA) guided intratumoral TNFerade gene delivery combined with chemoradiation in the treatment of locally advanced pancreatic cancer (LAPC). Gastrointest. Endosc. 63(5), AB93 (2006).
37. Posner M, Chang KJ, Rosemurgy A. et al. Multi-center Phase II/III randomized controlled clinical trial using TNFerade combined with chemoradiation in patients with locally advanced pancreatic cancer (LAPC). ASCO Annual Meeting Proceedings Part I. J. Clin. Oncol. 25(18 Suppl.), 4518 (2007).
38. Kothary N, Heit JJ, Louie JD et al. Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy. J. Vasc. Interv. Radiol. 20(2), 235-239 (2009).
39. Albashir S, Sawhney MS, Pleskow D et al. EUS-guided fiducial placement for cyberknife treatment of pancreatic cancer. Gastrointest. Endosc. 67(5), AB223-AB224 (2008).
40. Antillon MR, Chang KJ. Endoscopic and endosonography guided fine-needle aspiration. Gastrointest. Endosc. Clin. N. Am. 10(4), 619-636 (2000).
41. Chang KJ. State of the art lecture: endoscopic ultrasound (EUS) and FNA in pancreatico - biliary tumors. Endoscopy 38(1), 56-60 (2006).
42. Affi A, Vazquez-Sequeiros E, Norton ID, Clain JE, Wiersema MJ. Acute extraluminal hemorrhage associated with EUS-guided fine needle aspiration: frequency and clinical significance. Gastrointest. Endosc. 53(2), 221-225 (2001).
43. Gress F, Michael H, Gelrud D et al. EUS-guided fine-needle aspiration of the pancreas: evaluation of pancreatitis as a complication. Gastrointest. Endosc. 56(6), 864-867 (2002).
44. Eloubeidi MA, Tamhane A, Varadarajulu S, Wilcox CM. Frequency of major complications after EUS-guided FNA of solid pancreatic masses: a prospective evaluation. Gastrointest. Endosc. 63(4), 622-629 (2006).
45. Schima W, Fugger R, Schober E et al. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT. AJR Am. J. Roentgenol. 179 (3), 717-724 (2002).
46. Soriano A, Castells A, Ayuso C et al. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am. J. Gastroenterol. 99(3), 492-501 (2004).
47. Dewitt J, Devereaux BM, Lehman GA, Sherman S, Imperiale TF. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin. Gastroenterol. Hepatol. 4(6), 717-725 (2006).
48. Arslan A, Buanes T, Geitung JT. Pancreatic carcinoma: MR, MR angiography and dynamic helical CT in the evaluation of vascular invasion. Eur. J. Radiol. 38(2), 151-159 (2001).
49. Phoa SS, Reeders JW, Stoker J, Rauws EA, Gouma DJ, Lameris JS. CT criteria for venous invasion in patients with pancreatic head carcinoma. Br. J. Radiol. 73(875), 1159-1164 (2000).
50. Valls C, Andia E, Sanchez A et al. Dual-phase helical CT of pancreatic, adenocarcinoma: assessment of resectability before surgery. AJR Am. J. Roentgenol. 178(4), 821-826 (2002).
51. O'Malley ME, Boland GW, Wood BJ, Fernandez-del Castillo C, Warshaw AL, Mueller PR. Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT. AJR Am. J. Roentgenol. 173(6), 1513-1518 (1999).
52. Wong JC, Lu DS. Staging of pancreatic adenocarcinoma by imaging studies. Clin. Gastroenterol. Hepatol. 6(12), 1301-1308 (2008).
53. Diehl SJ, Lehmann KJ, Sadick M, Lachmann R, Georgi M. Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology, 206(2), 373-378 (1998).
54. Trede M, Rumstadt B, Wendl K et al. Ultrafast magnetic resonance imaging improves the staging of pancreatic tumors. Ann. Surg. 226(4), 393-405; discussion 405-397 (1997).
55. Ainsworth AP, Rafaelsen SR, Wamberg PA, Durup J, Pless TK, Mortensen MB. Is there a difference in diagnostic accuracy and clinical impact between endoscopic ultrasonography and magnetic resonance cholangiopancreatography? Endoscopy 35(12), 1029-1032 (2003).
56. Gambhir SS, Czernin J, Schwimmer J, Silverman DH. Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J. Nucl. Med. 42(5 Suppl.), S1-S93 (2001).
57. Orlando LA, Kulasingam SL, Matchar DB. Meta-analysis: the detection of pancreatic malignancy with positron emission tomography. Aliment. Pharmacol. Ther. 20(10), 1063-1070 (2004).
58. Lemke AJ, Niehues SM, Hosten N et al. Retrospective digital image fusion of multidetector CT and 18F-FDG PET: clinical value in pancreatic lesions - a prospective study with 104 patients. J. Nucl. Med. 45(8), 1279-1286 (2004).
59. Heinrich S, Goerres GW, Schafer M et al. Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann. Surg. 242(2), 235-243 (2005).
60. Farma JM, Santillan AA, Melis M et al. PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms. Ann. Surg. Oncol. 15(9), 2465-2471 (2008).
61. Higashi T, Saga T, Nakamoto Y et al. Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) - usefulness and limitations in "clinical reality". Ann. Nucl. Med. 17(4), 261-279 (2003).
62. Nishiyama Y, Yamamoto Y, Yokoe K et al. Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer. Ann. Nucl. Med. 19(6), 491-497 (2005).
63. Strobel K, Heinrich S, Bhure U et al. Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer. J. Nucl. Med. 49(9), 1408-1413 (2008).
64. Judah JR, Draganov PV. Intraductal biliary and pancreatic endoscopy: an expanding scope of possibility. World J. Gastroenterol. 14(20), 3129-3136 (2008).
65. Reavis KM, Melvin WS. Advanced endoscopic technologies. Surg. Endosc. 22(6), 1533-1546 (2008).
66. Mansfield SD, Scott J, Oppong K et al. Comparison of multislice computed tomography and endoscopic ultrasonography with operative and histological findings in suspected pancreatic and periampullary malignancy. Br. J. Surg. 95(12), 1512-1520 (2008).
67. Greene FL, American Joint Committee on cancer. AJCC Cancer Staging Manual. Springer, NY, USA (2002).
68. Ariyama J, Suyama M, Satoh K, Sai J. Imaging of small pancreatic ductal adenocarcinoma. Pancreas 16(3), 396-401 (1998).
69. Schwarz M, Pauls S, Sokiranski R et al. Is a preoperative multidiagnostic approach to predict surgical resectability of periampullary tumors still effective? Am. J. Surg. 182(3), 243-249 (2001).
70. Seewald S, Omar S, Imazu H et al. Reliability of EUS in exclusion of pancreatic cancer - results of the Hamburg - Eppendorf study. Gastrointest. Endosc. 63(5) (2006).
71. Agarwal B, Krishna NB, Labundy JL, Safdar R, Akduman EI. EUS and/or EUS-guided FNA in patients with CT and/or magnetic resonance imaging findings of enlarged pancreatic head or dilated pancreatic duct with or without a dilated common bile duct. Gastrointest. Endosc. 68(2), 237-242 (2008).
72. Bhutani MS, Gress FG, Giovannini M et al. The No Endosonographic Detection of Tumor (NEST) study: a case series of pancreatic cancers missed on endoscopic ultrasonography. Endoscopy 36(5), 385-389 (2004).
73. Eloubeidi MA, Varadarajulu S, Desai S, Wilcox CM. Value of repeat endoscopic ultrasound-guided fine needle aspiration for suspected pancreatic cancer. J. Gastroenterol. Hepatol. 23(4), 567-570 (2008).
74. Fusaroli P, Manta R, Fedeli P et al. The influence of endoscopic biliary stents on the accuracy of endoscopic ultrasound for pancreatic head cancer staging. Endoscopy 39(9), 813-817 (2007).
75. Shami VM, Mahajan A, Sundaram V, Davis EM, Loch MM, Kahaleh M. Endoscopic ultrasound staging is adversely affected by placement of a self-expandable metal stent: fact or fiction? Pancreas 37(4), 396-398 (2008).
76. Bettini N, Moutardier V, Turrini O et al. Preoperative locoregional re-evaluation by endoscopic ultrasound in pancreatic ductal adenocarcinoma after neoadjuvant chemoradiation. Gastroenterol. Clin. Biol. 29(6-7), 659-663 (2005).
77. White RR, Paulson EK, Freed KS et al. Staging of pancreatic cancer before and after neoadjuvant chemoradiation. J. Gastrointest. Surg. 5(6), 626-633 (2001).
78. Varadarajulu S, Tamhane A, Eloubeidi MA. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Gastrointest. Endosc. 62(5), 728-736 (2005).
79. Hirche TO, Ignee A, Barreiros AP et al. Indications and limitations of endoscopic ultrasound elastography for evaluation of focal pancreatic lesions. Endoscopy 40(11), 910-917 (2008).
80. Saftoiu A, Vilmann P, Gorunescu F et al. Neural network analysis of dynamic sequences of EUS elastography used for the differential diagnosis of chronic pancreatitis and pancreatic cancer. Gastrointest. Endosc. 68(6), 1086-1094 (2008).
81. Colvin EK, Chang DC, Merrett ND, Kench JG, Biankin AV. Individualized therapy for pancreatic cancer. J. Gastroenterol. Hepatol. 23(12), 1779-1782 (2008).
82. Biankin AV, Morey AL, Lee CS et al. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma. J. Clin. Oncol. 20(23), 4531-4542 (2002).
83. Segara D, Biankin AV, Kench JG et al. Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia. Clin. Cancer Res. 11(9), 3587-3596 (2005).
84. Skalicky DA, Kench JG, Segara D et al. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma. Cancer Epidemiol. Biomarkers Prev. 15(10), 1941 (2006).
85. Murphy NC, Scarlett CJ, Kench JG et al. Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma. Br. J. Cancer 98(3), 537-541 (2008).
86. Chang DK, Merrett ND, Biankin AV. Improving outcomes for operable pancreatic cancer: is access to safer surgery the problem? J. Gastroenterol. Hepatol. 23(7 Pt 1), 1036-1045 (2008).